AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 2 |
Visa
V
|
+$283M |
| 3 |
CVS Health
CVS
|
+$195M |
| 4 |
Texas Instruments
TXN
|
+$188M |
| 5 |
Progressive
PGR
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$274M |
| 2 |
Microsoft
MSFT
|
+$263M |
| 3 |
Comcast
CMCSA
|
+$248M |
| 4 |
Amphenol
APH
|
+$238M |
| 5 |
Elevance Health
ELV
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.59% |
| 2 | Financials | 14.66% |
| 3 | Healthcare | 14.25% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COR
1151
DELISTED
Coresite Realty Corporation
COR
| $4.64M | ﹤0.01% |
62,668
+2,900
| +5% | +$235K |
|
1152
Kforce
KFRC
$983M
| $4.64M | ﹤0.01% |
226,280
+129,750
| +134% | +$2.42M |
|
1153
Invesco Mortgage Capital
IVR
$776M
| $4.63M | ﹤0.01% |
30,408
+5,984
| +25% | +$899K |
|
1154
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
| $4.6M | ﹤0.01% |
37,324
+11,755
| +46% | +$1.45M |
|
|
HZNP
1155
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.59M | ﹤0.01% |
253,260
-8,900
| -3% | -$174K |
|
1156
Avnet
AVT
$7.33B
| $4.59M | ﹤0.01% |
111,788
-51,883
| -32% | -$2.12M |
|
|
FSP
1157
Franklin Street Properties
FSP
$44.8M
| $4.56M | ﹤0.01% |
361,622
+96,067
| +36% | +$1.21M |
|
1158
W.R. Berkley
WRB
$28B
| $4.54M | ﹤0.01% |
265,434
-2,767
| -1% | -$47.9K |
|
1159
Seaboard Corp
SEB
$4.52B
| $4.52M | ﹤0.01% |
1,314
+450
| +52% | +$1.4M |
|
|
CBL
1160
DELISTED
CBL& Associates Properties, Inc.
CBL
| $4.51M | ﹤0.01% |
371,671
+17,672
| +5% | +$215K |
|
1161
Vanda Pharmaceuticals
VNDA
$312M
| $4.5M | ﹤0.01% |
270,678
+144,600
| +115% | +$1.95M |
|
1162
Manhattan Associates
MANH
$8.97B
| $4.49M | ﹤0.01% |
77,911
+17,171
| +28% | +$1.03M |
|
1163
Pediatrix Medical
MD
$2.16B
| $4.48M | ﹤0.01% |
67,625
-680
| -1% | -$46.5K |
|
1164
RLI Corp
RLI
$5.68B
| $4.48M | ﹤0.01% |
131,058
+326
| +0.2% | +$11.2K |
|
1165
RenaissanceRe
RNR
$13.8B
| $4.45M | ﹤0.01% |
37,022
-722
| -2% | -$85.1K |
|
|
ALE
1166
DELISTED
Allete
ALE
| $4.45M | ﹤0.01% |
74,587
| – | – |
|
|
FBC
1167
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $4.44M | ﹤0.01% |
159,860
+82,070
| +106% | +$2.22M |
|
|
EV
1168
DELISTED
Eaton Vance Corp.
EV
| $4.43M | ﹤0.01% |
113,568
+31,936
| +39% | +$1.22M |
|
1169
Polaris
PII
$4.15B
| $4.43M | ﹤0.01% |
57,195
+10,730
| +23% | +$932K |
|
|
CMD
1170
DELISTED
Cantel Medical Corporation
CMD
| $4.43M | ﹤0.01% |
56,793
-17,677
| -24% | -$1.28M |
|
1171
Spire
SR
$4.92B
| $4.43M | ﹤0.01% |
69,476
-16,850
| -20% | -$1.13M |
|
|
WSR
1172
DELISTED
Whitestone REIT
WSR
| $4.43M | ﹤0.01% |
318,979
+299,940
| +1,575% | +$4.48M |
|
|
CUDA
1173
DELISTED
Barracuda Networks, Inc.
CUDA
| $4.42M | ﹤0.01% |
173,450
+86,310
| +99% | +$1.89M |
|
1174
Primerica
PRI
$9.81B
| $4.41M | ﹤0.01% |
83,167
-70
| -0.1% | -$3.87K |
|
|
AMAG
1175
DELISTED
AMAG Pharmaceuticals
AMAG
| $4.38M | ﹤0.01% |
178,813
+114,640
| +179% | +$2.87M |
|
Similar funds
AllianceBernstein's Q3 2016 Portfolio in Review
As of Q3 2016, AllianceBernstein held 3,058 positions worth $118B, up 2% from $116B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q3 2016 filing shows 95 new, 1,049 increased, 1,331 reduced and 82 closed positions. Its largest new stake was Teva Pharmaceuticals: 2,294,681 shares worth $106M. The largest sale was Pfizer, an estimated $274M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q3 2016 buy was Teva Pharmaceuticals: 2,294,681 shares worth $106M.
- AllianceBernstein added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $567M increase.
- AllianceBernstein's biggest Q3 2016 reduction was Pfizer, cutting an estimated $274M.
- AllianceBernstein fully exited EMC CORPORATION in Q3 2016, selling an estimated $99.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $118B portfolio in Q3 2016.
- AllianceBernstein opened 95 new positions and closed 82 in Q3 2016.
- AllianceBernstein's portfolio value rose 2% quarter-over-quarter to $118B.
Based on AllianceBernstein's 13F filing for Q3 2016, filed 10 Nov 2016.